CRYOPORT, INC. Operating Leases, Future Minimum Payments, Due in Five Years
CRYOPORT, INC. (CYRX) had Operating Leases, Future Minimum Payments, Due in Five Years of $198.22 thousand as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2020-03-10
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Five Years $198.22K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $198.22K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $454.98K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $341.70K.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2019-03-31 | $198.22K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $198.22K 10-K · filed 2020-03-10 |
| 2017-12-31 | $454.98K 10-K · filed 2018-03-08 |
| 2016-12-31 | $341.70K 10-KT · filed 2017-03-13 |
| 2016-03-31 | $334.20K 10-K · filed 2016-06-28 |
| 2013-03-31 | $0.00 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |